Literature DB >> 12871057

Targeting the lung: preclinical and comparative evaluation of anticancer aerosols in dogs with naturally occurring cancers.

Chand Khanna1, David M Vail.   

Abstract

Pet dogs with naturally occurring cancers offer a novel opportunity for the study of both cancer biology and therapy. The following review will provide the rationale for the use of these spontaneous cancer models in translational research, particularly in the development of anticancer aerosols. A summary of work involving pet dogs with primary and metastatic cancers to the lung and the investigation of therapeutic chemotherapy and cytokine immunotherapy aerosols will be presented.

Entities:  

Mesh:

Substances:

Year:  2003        PMID: 12871057     DOI: 10.2174/1568009033481903

Source DB:  PubMed          Journal:  Curr Cancer Drug Targets        ISSN: 1568-0096            Impact factor:   3.428


  10 in total

1.  Feasibility and effectiveness of inhaled carboplatin in NSCLC patients.

Authors:  Paul Zarogoulidis; Ellada Eleftheriadou; Iordanis Sapardanis; Vasiliki Zarogoulidou; Helliel Lithoxopoulou; Theodoros Kontakiotis; Nikolaos Karamanos; George Zachariadis; Maria Mabroudi; Athanasios Zisimopoulos; Kostantinos Zarogoulidis
Journal:  Invest New Drugs       Date:  2011-07-08       Impact factor: 3.850

2.  Breed-specific incidence rates of canine primary bone tumors--a population based survey of dogs in Norway.

Authors:  Kristin P Anfinsen; Tom Grotmol; Oyvind S Bruland; Thora J Jonasdottir
Journal:  Can J Vet Res       Date:  2011-07       Impact factor: 1.310

3.  Pharmacokinetic Profile of Inhaled Submicron Particle Paclitaxel (NanoPac®) in a Rodent Model.

Authors:  James Verco; William Johnston; Michael Baltezor; Philip J Kuehl; Andrew Gigliotti; Steven A Belinsky; Anita Lopez; Ronald Wolff; Lauren Hylle; Gere diZerega
Journal:  J Aerosol Med Pulm Drug Deliv       Date:  2018-10-25       Impact factor: 2.849

Review 4.  Comparative oncology today.

Authors:  Melissa C Paoloni; Chand Khanna
Journal:  Vet Clin North Am Small Anim Pract       Date:  2007-11       Impact factor: 2.093

Review 5.  Inhaled chemotherapy in lung cancer: future concept of nanomedicine.

Authors:  Paul Zarogoulidis; Ekaterini Chatzaki; Konstantinos Porpodis; Kalliopi Domvri; Wolfgang Hohenforst-Schmidt; Eugene P Goldberg; Nikos Karamanos; Konstantinos Zarogoulidis
Journal:  Int J Nanomedicine       Date:  2012-03-22

6.  Inhaled Submicron Particle Paclitaxel (NanoPac) Induces Tumor Regression and Immune Cell Infiltration in an Orthotopic Athymic Nude Rat Model of Non-Small Cell Lung Cancer.

Authors:  James Verco; William Johnston; Michael Frost; Michael Baltezor; Philip J Kuehl; Anita Lopez; Andrew Gigliotti; Steven A Belinsky; Ronald Wolff; Gere diZerega
Journal:  J Aerosol Med Pulm Drug Deliv       Date:  2019-07-26       Impact factor: 2.849

7.  Launching a novel preclinical infrastructure: comparative oncology trials consortium directed therapeutic targeting of TNFalpha to cancer vasculature.

Authors:  Melissa C Paoloni; Anita Tandle; Christina Mazcko; Engy Hanna; Stefan Kachala; Amy Leblanc; Shelley Newman; David Vail; Carolyn Henry; Douglas Thamm; Karin Sorenmo; Amin Hajitou; Renata Pasqualini; Wadih Arap; Chand Khanna; Steven K Libutti
Journal:  PLoS One       Date:  2009-03-30       Impact factor: 3.240

8.  Fluoroquinolone-mediated inhibition of cell growth, S-G2/M cell cycle arrest, and apoptosis in canine osteosarcoma cell lines.

Authors:  Kyoung won Seo; Roseline Holt; Yong-Sam Jung; Carlos O Rodriguez; Xinbin Chen; Robert B Rebhun
Journal:  PLoS One       Date:  2012-08-21       Impact factor: 3.240

9.  Peroxisome proliferator activated receptor γ protein expression is asymmetrically distributed in primary lung tumor and metastatic to lung osteosarcoma samples and does not correlate with gene methylation.

Authors:  Chamisa L Herrera; Dae Young Kim; Senthil R Kumar; Jeffrey N Bryan
Journal:  BMC Vet Res       Date:  2015-09-04       Impact factor: 2.741

10.  Canine pulmonary adenocarcinoma tyrosine kinase receptor expression and phosphorylation.

Authors:  Evan T Mariotti; Christopher Premanandan; Gwendolen Lorch
Journal:  BMC Vet Res       Date:  2014-01-14       Impact factor: 2.741

  10 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.